Tag: PSA

  • Dr. Krieger and Dr. Savatta discuss prostate cancer and PSA screening

    In June of 2013 I joined my partner and president of UGNJ, Alan Krieger, MD to educate the public about prostate cancer. Recently a governmental agency recommended against prostate cancer screening with PSA without recommending a replacement for PSA. We had a thorough discussion about the need to screen for prostate cancer and what men…

  • AUA: Five tests, treatments may be unnecessary | Urology Times

    The AUA’s list identified the following five recommendations: A routine bone scan is unnecessary in men with low-risk prostate cancer. Do not prescribe testosterone to men with erectile dysfunction who have normal testosterone levels. Do not order creatinine or upper tract imaging in men with BPH. Do not treat an elevated PSA with antibiotics for…

  • They got it wrong again – www.phillyburbs.com: Reader Voices

    While prostate cancer is still the second leading cause of death for American men, early detection and advanced treatments have combined to reduce the mortality rate from prostate cancer by nearly 40 percent in the last two decades. During that same time period, we have seen dramatically less metastatic disease than in my earliest days…

  • Prostate-Cancer Mortality at 11 Years of Follow-up — NEJM

    After a median follow-up of 11 years in the core age group, the relative reduction in the risk of death from prostate cancer in the screening group was 21% rate ratio, 0.79; 95% confidence interval [CI], 0.68 to 0.91; P=0.001, and 29% after adjustment for noncompliance. The absolute reduction in mortality in the screening group…

  • Organ-confined disease more common in screen-detected prostate cancer

    Source: MedWire News Prostate cancers detected by screening have a higher rate of organ-confined disease and a lower rate of extracapsular extension and positive surgical margins than non-screen-detected cancers, say researchers. The widespread use of prostate cancer screening had led to stage migration, with more cancers detected at a lower stage, which has led to…

  • Active Surveillance for Prostate Cancer Patients

    From Medscape May 12, 2008 — The urine test for the PCA3 gene, already marketed for use in diagnosing prostate cancer, could also be useful in prognostication. It might have clinical application in selecting men with low-grade and low-volume tumors who would be suitable candidates for active surveillance, say researchers writing in the May issue…

  • A Step Backward: The ACPM Recommendations on Prostate Cancer Screening

    Medscape article summarizing PSA recommendations: The most aggressive screening protocol is from the NCCN. NCCN guidelines start from the premise that the patient has made a decision to seek early prostate cancer detection. They recommend beginning screening at age 40. The baseline PSA level, race, and family history are then used to determine the subsequent…

  • Screening for prostate cancer

    The controversy over screening for prostate cancer will continue. clipped from www.medscape.com Information is not adequate to recommend screening men for prostate cancer with digital rectal examination or measurement of prostate-specific antigen (PSA), according to a position statement by the American College of Preventive Medicine (ACPM) published in the February issue of the American Journal…

  • Testosterone and prostate size

    Testosterone makes prostates grow larger and makes prostate cancer grow more quickly. I came across a study that looks at prostate size and testosterone levels: clipped from www.urotoday.com Relationship between Serum Testosterone and Measures of Benign Prostatic Hyperplasia in Aging Men – Abstract In our study, the serum testosterone levels in aging men did not…